8-K - MIRA Pharmaceuticals, Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

. Other Events. On December 5, 2025, MIRA Pharmaceuticals, Inc. (the “Company”) filed a prospectus supplement (the “Current Prospectus Supplement”) to increase

Other Event

$15.2M$7.0M$15.2M

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 5.01 Opinion of Pearl Cohen Zedek Latzer Baratz LLP 23.1 Consent of Pearl Cohen Zedek

Exhibits Only

Exhibits (2)

5.1

EX-5.1

8-K